Moore Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-157,292
| Closed | -$28.9M | – | 960 |
|
|
2021
Q2 | $28.9M | Sell |
157,292
-27,708
| -15% | -$5.09M | 0.41% | 40 |
|
|
2021
Q1 | $28.3M | Buy |
185,000
+115,000
| +164% | +$17.6M | 0.36% | 39 |
|
|
2020
Q4 | $10.9M | Buy |
+70,000
| New | +$10.9M | 0.12% | 108 |
|
|
2016
Q1 | – | Sell |
-30,000
| Closed | -$5.72M | – | 338 |
|
|
2015
Q4 | $5.72M | Buy |
+30,000
| New | +$5.72M | 0.18% | 128 |
|